• F. Stephen Hodi, Jr., MD

    Director, Melanoma Cancer,
    Director, Center for Immuno-Oncology,
    Sharon Crowley Martin Chari in Melanoma,
    Dana-Farber Cancer Institute

    Professor of Medicine,
    Harvard Medical School


    Dr. Hodi is the Director of the Melanoma Center and the Center for Immuno-Oncology at Dana-Farber/Brigham and Women’s Cancer Center and Associate Professor of Medicine at Harvard Medical School. He received his MD degree from Cornell University Medical College in 1992. Dr. Hodi competed his postdoctoral training in In¬ternal Medicine at the Hospital of the University of Pennsylvania, and Medical Oncology training at Dana-Farber cancer Institute where he joined the faculty in 1998.

    His research focuses on gene therapy, the development of immune therapies, and first into human studies for malignant melanoma. Dr. Hodi is a member of the National Comprehensive Cancer Network, the American Society of Clinical Oncology, the American Association for Cancer Research, the Eastern Cooperative Oncology Group Melanoma Committee, the Society for Immunotherapy of Cancer, formerly the International Society for the Biological Therapy of Cancer, the European Academy of Tumor Immunology and a founding member of the Society for Melanoma Research.

    His clinical investigation efforts have pioneered the use of immune checkpoint blockade and combinatorial approaches to treat cancer.